Discovery and Early Development of TMC647055, a Non-Nucleoside Inhibitor of the Hepatitis C Virus NS5B Polymerase

被引：25

作者：

Cummings, Maxwell D. ^{[1
]}

Lin, Tse-I ^{[1
]}

Hu, Lili ^{[1
]}

Tahri, Abdellah ^{[1
]}

McGowan, David ^{[1
]}

Amssoms, Katie ^{[1
]}

Last, Stefaan ^{[1
]}

Devogelaere, Benoit ^{[1
]}

Rouan, Marie-Claude ^{[1
]}

Vijgen, Leen ^{[1
]}

Berke, Jan Martin ^{[1
]}

Dehertogh, Pascale ^{[1
]}

Fransen, Els ^{[1
]}

Cleiren, Erna ^{[1
]}

van der Helm, Liesbet ^{[1
]}

Fanning, Gregory ^{[1
]}

Nyanguile, Origene ^{[1
]}

Simmen, Kenny ^{[1
]}

Van Remoortere, Pieter ^{[1
]}

Raboisson, Pierre ^{[1
]}

Vendeville, Sandrine ^{[1
]}

机构：

[1] Janssen Infect Dis BVBA, B-2340 Beerse, Belgium

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2014年 / 57卷 / 05期

关键词：

DEPENDENT RNA-POLYMERASE; FINGER-LOOP INHIBITORS; GENOTYPE; INFECTION; PROTEASE INHIBITOR; IN-VITRO; MACROCYCLIC INHIBITORS; ALLOSTERIC INHIBITORS; HCVNS5B POLYMERASE; ANTIVIRAL ACTIVITY; HCV;

D O I：

10.1021/jm401396p

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Structure-based macrocyclization of a 6-carboxylic acid indole chemotype has yielded potent and selective finger-loop inhibitors of the hepatitis C virus (HCV) NS5B polymerase. Lead optimization in conjunction with in vivo evaluation in rats identified several compounds showing 0) nanomolar potency in HCV replicon cells, (ii) limited toxicity and off-target activities, and (iii) encouraging preclinical pharmacokinetic profiles characterized by high liver distribution. This effort culminated in the identification of TMC647055 (10a), a nonzwitterionic 17-membered-ring macrocycle characterized by high affinity, long polymerase residence time, and broad genotypic coverage. In vitro results of the combination of 10a with the HCV protease inhibitor TMC435 (simeprevir) supported an evaluation of this combination in patients with regard to virus suppression and resistance emergence. In a phase 1b trial with HCV genotype 1-infected patients, 10a was considered to be safe and well-tolerated and demonstrated potent antiviral activity, which was further enhanced in a combination study with TMC435.

引用

页码：1880 / 1892

页数：13

共 42 条

[31] Discovery of (7R)-14-Cyclohexyl-7-{[2-(dimethylamino)ethyl](methyl) amino}-7,8-dihydro-6H-indolo[1,2-e][1,5]benzoxazocine-11-carboxylic Acid (MK-3281), a Potent and Orally Bioavailable Finger-Loop Inhibitor of the Hepatitis C Virus NS5B Polymerase [J].

Narjes, Frank ;

Crescenzi, Benedetta ;

Ferrara, Marco ;

Habermann, Jorg ;

Colarusso, Stefania ;

Ferreira, Maria del Rosario Rico ;

Stansfield, Ian ;

Mackay, Angela Claire ;

Conte, Immacolata ;

Ercolani, Caterina ;

Zaramella, Simone ;

Palumbi, Maria-Cecilia ;

Meuleman, Philip ;

Leroux-Roels, Geert ;

Giuliano, Claudio ;

Fiore, Fabrizio ;

Di Marco, Stefania ;

Baiocco, Paola ;

Koch, Uwe ;

Migliaccio, Giovanni ;

Altamura, Sergio ;

Laufer, Ralph ;

De Francesco, Raffaele ;

Rowley, Michael .

JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (01) :289-301

[32] Binding-site identification and genotypic profiling of hepatitis C virus polymerase inhibitors [J].

Pauwels, Frederik ;

Mostmans, Wendy ;

Quirynen, Ludo M. M. ;

van der Helm, Liesbet ;

Boutton, Carlo W. ;

Rueff, Anne-Stphanie ;

Cleiren, Erna ;

Raboisson, Pierre ;

Surleraux, Dominique ;

Nyanguile, Origene ;

Simmen, Kenneth A. .

JOURNAL OF VIROLOGY, 2007, 81 (13) :6909-6919

[33] Boceprevir for Untreated Chronic HCV Genotype 1 Infection [J].

Poordad, Fred ;

McCone, Jonathan, Jr. ;

Bacon, Bruce R. ;

Bruno, Savino ;

Manns, Michael P. ;

Sulkowski, Mark S. ;

Jacobson, Ira M. ;

Reddy, K. Rajender ;

Goodman, Zachary D. ;

Boparai, Navdeep ;

DiNubile, Mark J. ;

Sniukiene, Vilma ;

Brass, Clifford A. ;

Albrecht, Janice K. ;

Bronowicki, Jean-Pierre ;

Colombato, L. ;

Curciarello, J. ;

Silva, M. ;

Tanno, H. ;

Terg, R. ;

Adler, M. ;

Langlet, P. ;

Lasser, L. ;

Nevens, F. ;

Anderson, F. ;

Bailey, R. ;

Bilodeau, M. ;

Cooper, C. ;

Feinman, S. V. ;

Heathcote, J. ;

Levstik, M. ;

Ramji, A. ;

Sherman, M. ;

Shafran, S. ;

Yoshida, E. ;

Achim, A. ;

Ben Ali, S. ;

Bigard, M-A. ;

Bonny, C. ;

Bourliere, M. ;

Boyer-Darrigrand, N. ;

Bronowicki, J-P. ;

Canva, V. ;

Couzigou, P. ;

De Ledinghen, V. ;

Guyader, D. ;

Hezode, C. ;

Larrey, D. ;

Latournerie, M. ;

Marcellin, P. .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (13) :1195-1206

[34] Structure-activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350 [J].

Raboisson, Pierre ;

de Kock, Herman ;

Rosenquist, Asa ;

Nilsson, Magnus ;

Salvador-Oden, Lourdes ;

Lin, Tse-I ;

Roue, Natalie ;

Ivanov, Vladimir ;

Wahling, Horst ;

Wickstrom, Kristina ;

Hamelink, Elizabeth ;

Edlund, Michael ;

Vrang, Lotta ;

Vendeville, Sandrine ;

Van de Vreken, Wim ;

McGowan, David ;

Tahri, Abdellah ;

Hu, Lili ;

Boutton, Carlo ;

Lenz, Oliver ;

Delouvroy, Frederic ;

Pille, Geert ;

Surleraux, Dominique ;

Wigerinck, Piet ;

Samuelsson, Bertil ;

Simmen, Kenneth .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (17) :4853-4858

[35] Structural Basis for Resistance of the Genotype 2b Hepatitis C Virus NS5B Polymerase to Site A Non-Nucleoside Inhibitors [J].

Rydberg, Edwin H. ;

Cellucci, Antonella ;

Bartholomew, Linda ;

Mattu, Marco ;

Barbato, Gaetano ;

Ludmerer, Steven W. ;

Graham, Donald J. ;

Altamura, Sergio ;

Paonessa, Giacomo ;

De Francesco, Raffaele ;

Migliaccio, Giovanni ;

Carfi, Andrea .

JOURNAL OF MOLECULAR BIOLOGY, 2009, 390 (05) :1048-1059

[36] Metabolic activation of carboxylic acids [J].

Skonberg, Christian ;

Olsen, Jorgen ;

Madsen, Kim Grimstrup ;

Hansen, Steen Honore ;

Grillo, Mark P. .

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2008, 4 (04) :425-438

[37] Mechanism of action and antiviral activity of benzimidazole-based allosteric inhibitors of the hepatitis C virus RNA-dependent RNA polymerase [J].

Tomei, L ;

Altamura, S ;

Bartholomew, L ;

Biroccio, A ;

Ceccacci, A ;

Pacini, L ;

Narjes, F ;

Gennari, N ;

Bisbocci, M ;

Incitti, I ;

Orsatti, L ;

Harper, S ;

Stansfield, I ;

Rowley, M ;

De Francesco, R ;

Migliaccio, G .

JOURNAL OF VIROLOGY, 2003, 77 (24) :13225-13231

[38] The Exploding Field of the HCV Polymerase Non-Nucleoside Inhibitors: Summary of a First Generation Compounds [J].

Tramontano, Enzo .

MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2008, 8 (12) :1298-1310

[39] Finger loop inhibitors of the HCV NS5b polymerase. Part II. Optimization of tetracyclic indole-based macrocycle leading to the discovery of TMC647055 [J].

Vendeville, Sandrine ;

Lin, Tse-I ;

Hu, Lili ;

Tahri, Abdellah ;

McGowan, David ;

Cummings, Maxwell D. ;

Amssoms, Katie ;

Canard, Maxime ;

Last, Stefaan ;

Van den Steen, Iris ;

Devogelaere, Benoit ;

Rouan, Marie-Claude ;

Vijgen, Leen ;

Berke, Jan Martin ;

Dehertogh, Pascale ;

Fransen, Els ;

Cleiren, Erna ;

Van der Helm, Liesbet ;

Fanning, Gregory ;

Van Emelen, Kristof ;

Nyanguile, Origene ;

Simmen, Kenny ;

Raboisson, Pierre .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (13) :4437-4443

[40] Telaprevir for Retreatment of HCV Infection [J].

Zeuzem, Stefan ;

Andreone, Pietro ;

Pol, Stanislas ;

Lawitz, Eric ;

Diago, Moises ;

Roberts, Stuart ;

Focaccia, Roberto ;

Younossi, Zobair ;

Foster, Graham R. ;

Horban, Andrzej ;

Ferenci, Peter ;

Nevens, Frederik ;

Muellhaupt, Beat ;

Pockros, Paul ;

Terg, Ruben ;

Shouval, Daniel ;

van Hoek, Bart ;

Weiland, Ola ;

Van Heeswijk, Rolf ;

De Meyer, Sandra ;

Luo, Don ;

Boogaerts, Griet ;

Polo, Ramon ;

Picchio, Gaston ;

Beumont, Maria .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (25) :2417-2428

← 1 2 3 4 5 →